This study is an International, multicenter, observational, retrospective trial on patients affected by PBL. The information collected aim to obtain data from the real-life diagnosis, staging, management and treatment and outcome of PBL patients. A centralized pathological review of pathological samples is planned to define the rate of accurate diagnosis and to define a recommended immunohistochemical diagnostic panel for PBL. In addition, exploratory analysis will be performed to better characterize PBL.
Age
15–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022
Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report
Age \> 18 years old
Availability of complete medical records
Availability of histopathological material requested by the study
You may not be if
Any other histology than PBL
Lack of complete medical records
Lack of histopathological material requested by the study